Intervention Drugs with Decreased Absorption (e.g., digoxin, atovaquone, posaconazole oral suspension*, fosfomycin) : Monitor for reduced therapeutic effect of the interacting drug.
Source: FDA drug label - metoclopramide hydrochloride
Metoclopramide Hydrochloride Interactions
Brand names: Metoclopramide
5 interactions on record
Examples Apomorphine, bromocriptine, cabergoline, levodopa, pramipexole, ropinirole, and rotigotine. Examples Apomorphine, bromocriptine, cabergoline, levodopa, pramipexole, ropinirole, rotigotine.
Source: FDA drug label - metoclopramide hydrochloride
( 7.1 , 7.2 ) 7.1 Effects of Other Drugs on Metoclopramide Table 3 displays the effects of other drugs on metoclopramide. Strong CYP2D6 Inhibitors, not Included in Antipsychotic Category Above Clinical Impact Increased plasma concentrations of metoclopramide; risk of exacerbation of extrapyramidal symptoms [see Clinical Pharmacology ( 12.3 )]. Intervention Reduce the Metoclopramide Orally Disintegrating Tablets dosage [ see Dosage and Administration ( 2.2 , 2.3 )] .
Source: FDA drug label - metoclopramide hydrochloride
Intervention Drugs with Decreased Absorption (e.g., digoxin, atovaquone, posaconazole oral suspension Interaction does not apply to posaconazole delayed-release tablet.
Source: FDA drug label - metoclopramide hydrochloride
acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).
Source: FDA drug label - metoclopramide hydrochloride